Dr. Gajanan Kulkarni

Myself Dr. Gajanan Kulkarni. I am from Bidar, Karnataka. I have completed my under graduation from JJMMC Davanagere and post graduation in psychiatry from NIMHANS, Bangalore. Following which I completed a fellowship in Neuropsychiatry from NIMHANS itself. I am affluent in Marathi, Kannada, Hindi and English. I began my journey in the field of Psychiatry in 2011. I also had the opportunity to teach undergraduate students for 1.5 years. My primary area of interest is in psychiatric conditions which co-occur with neurological and neurosurgical conditions. I am also trained in assessing and medical management of various psychiatric conditions in adults and the elderly such as Depression, Anxiety, Obsessive Compulsive Disorder, Bipolar affective disorder, Psychosis & Schizophrenia.
Currently I have been practising at Magna Centres for Obesity, Diabetes & Endocrinology Bangalore, Apollo speciality hospital, Jayanagar Bangalore from 2019 onwards.

Dr. Gajanan Kulkarni

Neuropsychiatrist

MBBS, Diploma in Psychiatry, M.D in Psychiatry, Post-Doctoral Fellowship in Neuropsychiatry

MBBS – Jagadguru Jayadeva Murugharajendra Medical College, Davangere, Karnataka – Rajiv Gandhi University of Health Sciences – 2008

Diploma in Psychiatry – National Institute of Mental Health and Neuro Sciences(NIMHANS) – 2013

M.D in Psychiatry – National Institute of Mental Health and Neuro Sciences(NIMHANS) – 2018

Post-Doctoral Fellowship in Neuropsychiatry – National Institute of Mental Health and Neuro Sciences(NIMHANS) – 2019

  • Junior resident in Department of Psychiatry – National Institute of Mental Health and Neurosciences, Bangalore – May 2011 to April 2013.
  • Junior resident (Non-PG) in Department of Psychiatry – National Institute of Mental Health and Neurosciences, Bangalore – July 2013 to June 2014.
  • Lecturer in Psychiatry – USM KLE, Belgaum – September 2014 to November 2015.
  • Senior Resident in Psychiatry – Gulbarga Institute of Medical Sciences, Gulbarga – December 2015 to June 2016
  • Junior resident in Department – Psychiatry at National Institute of Mental Health and Neurosciences, Bangalore – July 2016 to June 2018.
  • Post-Doctoral Fellow in Neuropsychiatry, Department of Psychiatry – National Institute of Mental Health and Neurosciences, Bangalore – July 2018 to June 2019.
  • Consultant Neuropsychiatrist Magna Centres for Obesity, Diabetes, and Endocrinology, Bangalore – Aug 2019 – Till date 
  • Visiting Consultant Neuropsychiatrist – Apollo Hospitals, Bangalore – Nov 2019 – Till date.

  • Kulkarni G, Narayanaswamy JC, Math SB. Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia. Indian J Pharmacol 2012; 44:649-50.
  • Kulkarni G, Mitra S, Nahar A, Mehta UM, Harish T, Thirthalli J. Low-Frequency rTMS as an alternative for suicidality and depression, in a patient with multiple medical comorbidities precluding ECT. Asian Journal of Psychiatry 2018; 34:14-15.10.1016/j.ajp.2018.03.020.
  • Shukla L, Reddy S, Kulkarni G et al. Alcohol Dependence, Hypoglycaemia, and Transient Movement Disorders. Prim Care Companion. CNS Disord. 2019;21(1):18l02308.https://doi.org/10.4088/PCC.18l02308.
  • Sharma, Ravi,Kulkarni G, Naveen KumarC et al. Antidepressant effects of Ketamine and ECT: a pilot comparison. Journal of Affective Disorders 2020; 276:260-266. https://doi.org/10.1016/j.jad.2020.07.066.
  • Kulkarni G, Mehta U, Das S et al. Novel CTSF Indel in a patient with Kufs disease and resistant schizophrenia: A case report. Schizophrenia Research 2021; 228:435-437. https://doi.org/10.1016/j.schres.2021.01.020.

Investigation of Cortical Reactivity Changes with Ketamine and Electroconvulsive Therapy in Patients with Depression” under the guidance of Dr. Jagadisha Thirthalli and Dr. Urvakhsh M Mehta.

  • Poster presentation: “Investigation of Cortical Reactivity Changes with Ketamine and Electroconvulsive Therapy in Patients with Depression” at T S Srinivasan – NIMHANS Knowledge Conclave 2019.
  • Oral presentation on “Prescription Drug Abuse in Patients with Headache” at CME on Neuro-Psychiatric Aspects of Headache, NIMHANS, March 2019.